跳至主要内容
临床试验/NCT01581229
NCT01581229已完成不适用

Early Use of Noninvasive Positive Pressure Ventilation for Intro-pulmonary Acute Lung Injury

Beijing Hospital1 个研究点 分布在 1 个国家目标入组 204 人开始时间: 2012年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
204
试验地点
1
主要终点
the numbers of patients who are actually intubated

研究概览

简要总结

To assess the safety and efficacy of noninvasive positive pressure ventilation for patients with intro-pulmonary pulmonary acute lung injury and compare this with high-concentration oxygen therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • acute onset;
  • a clinical presentation of respiratory distress;
  • arterial oxygen tension/inspired oxygen fraction (PaO2/FIO2) < 300 mmHg but > 200 mmHg while breathing oxygen delivered by a conventional Venturi device at a maximum concentration (50%);
  • presence of bilateral pulmonary infiltrates on posteroanterior chest radiograph;
  • no evidence of left heart failure as assessed by echocardiography and/or a pulmonary artery wedge pressure of <18 mm Hg.
  • the cause of ALI is consider to be intro-pulmonary.

排除标准

  • age <18 yrs;
  • Glasgow Coma Scale < 11;
  • airway or facial injury;
  • pneumothorax or pneumomediastinum;
  • unable to spontaneously clear secretions from the airways;
  • cardiogenic shock or severe hemodynamic instability (systolic blood pressure <90 mmHg associated with decreased urinary output (<20 mL.h-1) despite fluid repletion and use of vasoactive agents) of other causes;
  • severe ventricular arrhythmia or unstable myocardial ischemia;
  • severe organ dysfunction (Sequential Organ Failure Assessment score > 3);
  • end-stage patients who were expected to survive < 6 months;
  • severe abdominal distension;
  • refusal to receive NPPV;
  • the cause of ALI is consider to be extrapulmonary;
  • unable to cooperate with NPPV application;
  • active upper gastrointestinal bleeding.

研究组 & 干预措施

Control

Active Comparator

干预措施: oxygen therapy (Procedure)

NPPV

Experimental

干预措施: noninvasive positive pressure ventilation (Procedure)

结局指标

主要结局

the numbers of patients who are actually intubated

时间窗: 1 year

numbers of patients who met the intubation criteria

时间窗: 1 year

次要结局

  • inhospital mortalities(1 year)
  • intensive care unit mortalities(1 year)

研究者

发起方
Beijing Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Chen Wang

vice president

Beijing Hospital

研究点 (1)

Loading locations...

相似试验

Early Use of Noninvasive Positive Pressure... | 临床试验